The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CAR-T Cell Immunotherapy Market Research Report 2025
Synopsis
The global CAR-T Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Immunotherapy.
Report Scope
The CAR-T Cell Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Kite Pharma
JW Therapeutics
Shanghai Fosun Pharmaceutical Group
Segment by Type
CD19
CD22
Other
Segment by Application
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
High Grade B Cell Lymphoma
DLBCL
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global CAR-T Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Immunotherapy.
Report Scope
The CAR-T Cell Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Kite Pharma
JW Therapeutics
Shanghai Fosun Pharmaceutical Group
Segment by Type
CD19
CD22
Other
Segment by Application
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
High Grade B Cell Lymphoma
DLBCL
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CD19
1.2.3 CD22
1.2.4 Other
1.3 Market by Application
1.3.1 Global CAR-T Cell Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Relapsed or Refractory Mantle Cell Lymphoma (MCL)
1.3.3 High Grade B Cell Lymphoma
1.3.4 DLBCL
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Cell Immunotherapy Market Perspective (2019-2030)
2.2 CAR-T Cell Immunotherapy Growth Trends by Region
2.2.1 Global CAR-T Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CAR-T Cell Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 CAR-T Cell Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 CAR-T Cell Immunotherapy Market Dynamics
2.3.1 CAR-T Cell Immunotherapy Industry Trends
2.3.2 CAR-T Cell Immunotherapy Market Drivers
2.3.3 CAR-T Cell Immunotherapy Market Challenges
2.3.4 CAR-T Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Cell Immunotherapy Players by Revenue
3.1.1 Global Top CAR-T Cell Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global CAR-T Cell Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global CAR-T Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR-T Cell Immunotherapy Revenue
3.4 Global CAR-T Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR-T Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapy Revenue in 2023
3.5 CAR-T Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players CAR-T Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into CAR-T Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR-T Cell Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2025-2030)
5 CAR-T Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR-T Cell Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CAR-T Cell Immunotherapy Market Size (2019-2030)
6.2 North America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CAR-T Cell Immunotherapy Market Size by Country (2019-2024)
6.4 North America CAR-T Cell Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Cell Immunotherapy Market Size (2019-2030)
7.2 Europe CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CAR-T Cell Immunotherapy Market Size by Country (2019-2024)
7.4 Europe CAR-T Cell Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Cell Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific CAR-T Cell Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-T Cell Immunotherapy Market Size (2019-2030)
9.2 Latin America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CAR-T Cell Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America CAR-T Cell Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Cell Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Cell Immunotherapy Introduction
11.1.4 Novartis AG Revenue in CAR-T Cell Immunotherapy Business (2019-2024)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Detail
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Cell Immunotherapy Introduction
11.2.4 Kite Pharma Revenue in CAR-T Cell Immunotherapy Business (2019-2024)
11.2.5 Kite Pharma Recent Development
11.3 JW Therapeutics
11.3.1 JW Therapeutics Company Detail
11.3.2 JW Therapeutics Business Overview
11.3.3 JW Therapeutics CAR-T Cell Immunotherapy Introduction
11.3.4 JW Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2019-2024)
11.3.5 JW Therapeutics Recent Development
11.4 Shanghai Fosun Pharmaceutical Group
11.4.1 Shanghai Fosun Pharmaceutical Group Company Detail
11.4.2 Shanghai Fosun Pharmaceutical Group Business Overview
11.4.3 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Introduction
11.4.4 Shanghai Fosun Pharmaceutical Group Revenue in CAR-T Cell Immunotherapy Business (2019-2024)
11.4.5 Shanghai Fosun Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CD19
Table 3. Key Players of CD22
Table 4. Key Players of Other
Table 5. Global CAR-T Cell Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CAR-T Cell Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global CAR-T Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global CAR-T Cell Immunotherapy Market Share by Region (2019-2024)
Table 9. Global CAR-T Cell Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global CAR-T Cell Immunotherapy Market Share by Region (2025-2030)
Table 11. CAR-T Cell Immunotherapy Market Trends
Table 12. CAR-T Cell Immunotherapy Market Drivers
Table 13. CAR-T Cell Immunotherapy Market Challenges
Table 14. CAR-T Cell Immunotherapy Market Restraints
Table 15. Global CAR-T Cell Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global CAR-T Cell Immunotherapy Market Share by Players (2019-2024)
Table 17. Global Top CAR-T Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapy as of 2023)
Table 18. Ranking of Global Top CAR-T Cell Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CAR-T Cell Immunotherapy Product Solution and Service
Table 22. Date of Enter into CAR-T Cell Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-T Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2019-2024)
Table 26. Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2025-2030)
Table 28. Global CAR-T Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2019-2024)
Table 30. Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2025-2030)
Table 32. North America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific CAR-T Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG CAR-T Cell Immunotherapy Product
Table 50. Novartis AG Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Kite Pharma Company Detail
Table 53. Kite Pharma Business Overview
Table 54. Kite Pharma CAR-T Cell Immunotherapy Product
Table 55. Kite Pharma Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 56. Kite Pharma Recent Development
Table 57. JW Therapeutics Company Detail
Table 58. JW Therapeutics Business Overview
Table 59. JW Therapeutics CAR-T Cell Immunotherapy Product
Table 60. JW Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 61. JW Therapeutics Recent Development
Table 62. Shanghai Fosun Pharmaceutical Group Company Detail
Table 63. Shanghai Fosun Pharmaceutical Group Business Overview
Table 64. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product
Table 65. Shanghai Fosun Pharmaceutical Group Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)
Table 66. Shanghai Fosun Pharmaceutical Group Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR-T Cell Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CAR-T Cell Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. CD19 Features
Figure 4. CD22 Features
Figure 5. Other Features
Figure 6. Global CAR-T Cell Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global CAR-T Cell Immunotherapy Market Share by Application: 2023 VS 2030
Figure 8. Relapsed or Refractory Mantle Cell Lymphoma (MCL) Case Studies
Figure 9. High Grade B Cell Lymphoma Case Studies
Figure 10. DLBCL Case Studies
Figure 11. Other Case Studies
Figure 12. CAR-T Cell Immunotherapy Report Years Considered
Figure 13. Global CAR-T Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global CAR-T Cell Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global CAR-T Cell Immunotherapy Market Share by Region: 2023 VS 2030
Figure 16. Global CAR-T Cell Immunotherapy Market Share by Players in 2023
Figure 17. Global Top CAR-T Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapy Revenue in 2023
Figure 19. North America CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America CAR-T Cell Immunotherapy Market Share by Country (2019-2030)
Figure 21. United States CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe CAR-T Cell Immunotherapy Market Share by Country (2019-2030)
Figure 25. Germany CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific CAR-T Cell Immunotherapy Market Share by Region (2019-2030)
Figure 33. China CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America CAR-T Cell Immunotherapy Market Share by Country (2019-2030)
Figure 41. Mexico CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa CAR-T Cell Immunotherapy Market Share by Country (2019-2030)
Figure 45. Turkey CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Novartis AG Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)
Figure 48. Kite Pharma Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)
Figure 49. JW Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)
Figure 50. Shanghai Fosun Pharmaceutical Group Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
